Stocktoria
Cullinan Therapeutics, Inc. CGEM
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-01-08
Cullinan Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 3,550,207 | $61.9M | 5.89% |
| Point72 Asset Management, L.P. | 905,376 | $12.9M | 1.5% |
| TWO SIGMA INVESTMENTS, LP | 522,047 | $7.4M | 0.87% |
| MILLENNIUM MANAGEMENT LLC | 366,582 | $5.2M | 0.61% |
| AQR CAPITAL MANAGEMENT LLC | 360,874 | $5.1M | 0.6% |
| RENAISSANCE TECHNOLOGIES LLC | 324,111 | $4.6M | 0.54% |
| CITADEL ADVISORS LLC | 292,378 | $4.2M | 0.49% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.